↓ Skip to main content

Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study

Overview of attention for article published in Arthritis Research & Therapy, November 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
4 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
61 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study
Published in
Arthritis Research & Therapy, November 2019
DOI 10.1186/s13075-019-1992-x
Pubmed ID
Authors

Teresa A. Simon, Maarten Boers, Marc Hochberg, Nicole Baker, Mary L. Skovron, Nitesh Ray, Sanket Singhal, Samy Suissa, Andres Gomez-Caminero

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 61 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 15%
Researcher 8 13%
Student > Bachelor 6 10%
Other 6 10%
Lecturer 4 7%
Other 12 20%
Unknown 16 26%
Readers by discipline Count As %
Medicine and Dentistry 26 43%
Pharmacology, Toxicology and Pharmaceutical Science 9 15%
Biochemistry, Genetics and Molecular Biology 5 8%
Nursing and Health Professions 3 5%
Engineering 1 2%
Other 0 0%
Unknown 17 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 November 2021.
All research outputs
#13,655,015
of 21,069,566 outputs
Outputs from Arthritis Research & Therapy
#1,998
of 2,831 outputs
Outputs of similar age
#203,751
of 346,776 outputs
Outputs of similar age from Arthritis Research & Therapy
#184
of 235 outputs
Altmetric has tracked 21,069,566 research outputs across all sources so far. This one is in the 33rd percentile – i.e., 33% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,831 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 346,776 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 235 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.